President and CEO
Board of Directors
“Our mission is to bridge treatment gaps for patients with rare diseases.”
Matt has more than 20 years of leadership experience in the pharmaceutical industry and has been president, chief executive officer and director of Strongbridge Biopharma plc since August of 2014. He brings extensive general management and commercial leadership experience to the company, including U.S. and global product launches, negotiation and execution of numerous business development transactions, significant experience in raising capital in the public markets, clinical development, and oversight of global technical operations.
Before joining Strongbridge, Matt was the chief commercial officer at Insmed, a publicly traded biopharmaceutical company. Prior to that, he served as senior vice president, head of global commercial operations at Shire Pharmaceuticals and also held senior positions at Bristol-Myers Squibb in brand management and payer marketing, and at Johnson & Johnson in various U.S. and global commercial roles.
Matt was previously the chairman of the board of directors at Mast Therapeutics, Inc., and currently serves on the board of directors of Strongbridge Biopharma, Savara Pharmaceuticals, Egalet Corporation, and is a volunteer board member of The Pennington School in Pennington, New Jersey.
Matt holds MBA and BSBA degrees from Central Michigan University and earned his JD from Michigan State University College of Law.